Shionogi Announces Positive Results from Phase 2 Trial of ...
Shionogi - 29 Jan 2025S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication.
RS virus
S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication.
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots
Reuters - 02 Jul 2025US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots ...
Shingles, RSV vaccines may protect older adults from dementia
CIDRAP - 02 Jul 2025Shingles, RSV vaccines may protect older adults from dementia ...
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
MedPage Today - 02 Jul 2025CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot ...
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
BioSpace - 30 Jun 2025Moderna, Merck, UroGen, Score RSV and Cancer Nods in June ...
Respiratory Illnesses Data Channel
Centers for Disease Control and Prevention | CDC (.gov) - 27 Jun 2025Respiratory Illnesses Data Channel ...
US CDC Accepts Ousted Vaccine Panel's Recommendations for RSV, Meningococcal Shots
U.S. News & World Report - 02 Jul 2025US CDC Accepts Ousted Vaccine Panel's Recommendations for RSV, Meningococcal Shots ...
CDC signs off on RSV guidance from ousted vaccine panel
FirstWord Pharma - 02 Jul 2025CDC signs off on RSV guidance from ousted vaccine panel ...
RSV vaccine access expanded to some people in their 50s, according to CDC website
thebusinessjournal.com - 02 Jul 2025RSV vaccine access expanded to some people in their 50s, according to CDC website ...
The European Respiratory Virus Surveillance Summary (ERVISS)
European Centre for Disease Prevention and Control - 27 Jun 2025The European Respiratory Virus Surveillance Summary (ERVISS) ...
Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2
nature.com - 01 Jul 2025Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2 ...
respiratory syncytial virus
Britannica - 25 Jun 2025respiratory syncytial virus ...
RSV vaccine access expanded to some people in their 50s, according to CDC website
Indiana Gazette Online - 02 Jul 2025RSV vaccine access expanded to some people in their 50s, according to CDC website ...
ACIP Recommends Enflonsia for RSV Prevention in Infants
Vaccine Advisor - 30 Jun 2025ACIP Recommends Enflonsia for RSV Prevention in Infants ...
Respiratory syncytial virus (RSV)
World Health Organization (WHO) - 25 Mar 2025Respiratory syncytial virus (RSV) ...
Severe Viral Respiratory Illness
Centers for Disease Control and Prevention | CDC (.gov) - 27 Jun 2025Severe Viral Respiratory Illness ...
WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025
World Health Organization (WHO) - 30 May 2025WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025 ...
FDA Approves Merck’s ENFLONSIA to Prevent RSV in Infants During First Season
The Healthcare Technology Report. - 02 Jul 2025FDA Approves Merck’s ENFLONSIA to Prevent RSV in Infants During First Season ...
RSV | Department of Health
Rhode Island Department of Health (.gov) - 08 May 2025RSV | Department of Health ...
CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies
Deltaplex News - 02 Jul 2025CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies ...